In the absence of virus-specific antibody, Ross River virus failed to activate either the classical or alternative complement pathways. Instead, it inhibited the cleavage of C3 via both pathways. The virus did not appear to act by disrupting C3bBb complexes or by preventing cleavage of factor B by factor D. Instead Ross River virus was found to interfere with the actual cleavage of C3 by activated factor B (C3bBb) of the alternative pathway and C4b2a of the classical pathway.
INTRODUCTION
Each year approximately 500 cases of a disease known as epidemic polyarthritis are diagnosed in Australia (Health and Medical Services of the State of Queensland Annual Reports, 1978 Reports, -1981 and in 1979 and 1980 tens of thousands of cases of the disease appeared in the Pacific region (Fiji, American Samoa, Cook Islands) (Aaskov et al., 1981 a; Tesh et al., 1981 ; . Epidemic polyarthritis is characterized by joint pain, particularly in the knees and the small joints of the hands and feet, often accompanied by fever, rash, muscle pain and paraesthesia (Nimmo, 1928; Mudge, 1977) . Symptoms last from 30 to 40 weeks. In Australia where the disease is endemic, there are approximately 50 subclinical infections for each clinical infection (Aaskov et al., 1981 c) . The causative agent of epidemic polyarthritis is Ross River virus, an Alphavirus (Doherty et al., 1963) . In adult mice (CBA, BALB/c, C57) infected intravenously with Ross River virus, viraemia disappears after 2 to 3 days, before haemagglutination inhibition (HI) or neutralizing antibody can be detected (J. G. Aaskov, unpublished results) . In human infection, in Australia, the incubation time from infection to onset of symptoms is estimated to be 7 to 9 days (Fraser & Cunningham, 1980) with antibody being detected at diagnosis (2 to 3 days after onset of symptoms) (Doherty et al., 1963) . It appears possible then that the low clinical infection rate could be due to inactivation and/or clearance of virus by non-specific immunological factors and that disease occurs only in those in whom virus infection becomes established during the 7 to 9 day incubation period. Ross River virus has also been found to cross the placenta in man (Aaskov et al., 1981 b) so if children infected in utero are found to be tolerant to the virus, non-specific immunological systems may play an important role in clearing virus and resisting re-infection.
Recent studies have shown that the complement system plays an important role in limiting infections in non-immune hosts (Hicks et al., 1978; Hirsch et al., 1981) . Sindbis, an Alphavirus which can cause symptoms in man and animals similar to Ross River virus, has been reported to activate both the alternative and classical pathways in the absence of antibody and this activation resulted in enhanced clearance of virus from infected tissue (Hirsch et al., 1980a, b) .
This study was designed to investigate the interaction between Ross River virus and the complement system and to determine what role complement might play in regulating Ross River virus infection.
METHODS
Virus. Ross River virus was purified from the culture supernatant of porcine kidney (PS-EK) cells (Gorman et aL, 1975) infected 48 to 72 h previously with the prototype strain of the virus (T48; 6th mouse passage). Purification involved a preliminary centrifugation (10000g for 30 min at 4 °C) to remove cell debris followed by centrifugation at 160000 g for 1-5 h at 4 °C to pellet virus, and a final banding (25000 r.p.m., 2.5 h, 4 °C, DAMON/IEC 402 swing-head rotor) on a 5 to 50~ potassium tartrate gradient. The single band of virus which resulted was recovered from the gradient, diluted in phosphate-buffered saline (PBS) pH 7.2, re-pelleted at 160000 g for l-5 h at 4 °C, resuspended in PBS and stored at -80 °C until use. When analysed by polyacrylamide gel electrophoresis (Laemmli, 1970) , the virus preparations showed only three bands of viral protein: nucleocapsid and two envelope proteins.
Infectious virus used for all experiments was quantified by measuring cytopathic effect in Vero cells in 96-well flat bottom microtitre trays (Linbro). Amounts of virus are expressed as TCIDso.
Serum and complement components. Guinea-pig sera were collected from normal and C4-deficient animals kept at the Department of Medical Microbiology, University of Mainz. Sera from representative animals in the colony contained no detectable neutralizing antibodies against Ross River virus. Human serum was collected from donors without detectable antibody against Ross River virus. Addition of Ross River virus to human or guinea-pig serum containing neutralizing antibody against this virus resulted in complement activation and cleavage of C3.
The following components were prepared by the methods indicated: factor B (Hamuro et al., 1978) , guinea-pig C3 (Meuer et ul., 1978) . human C3 (Tack & Prahl, 1976) , factor D (Brade et al., 1974b) , factor H (formerly fllH) 198 l) . Cobra venom factor-factor B complex (VFBb) was prepared as described by BitterSuermann et al. (1972) and purified by filtration on Sephadex G-200 (Pharmacia).
The haemolytic assays used to measure levels of guinea-pig and human C3 have been described previously (Bitter-Suermann et al., 1970; Dierich & Landen, 1979) . Briefly, sheep erythrocytes (E) were sensitized with rabbit anti-sheep antibody (Amboceptor 6000; Behring) and then incubated for l0 min at 37 °C with a 1:40 dilution of cobra venom (VF, Cordis Labs., U.S.A.)-treated guinea-pig serum. This resulted in the generation of C1C4bC2a complexes on the surface of the sheep erythrocytes. This erythrocyte-antibody-complement complex will be termed EAI42. In some instances EA 142 was generated using guinea-pig C1, human C4 and oxidized human C2 (Dierich & Landen, 1979) . EAI42 was washed twice in ice-cold half ionic strength barbitone-buffered saline pH 7.5 (VBSS) containing 0-17 M-sucrose, 0.15 mM-Ca 2+ and 1 mM-Mg 2+ and made up to a concentration of 1.3 x 108 cells/ml before use.
The effect of Ross River virus on various complement reactions was quantified by measuring residual levels of functional C3 in reaction mixtures. The haemolytic activity of C3 was determined by first measuring, spectrophotometrically (2 = 412 nm), haemoglobin released from EA142 in reaction mixtures and then calculating the number of functional units of C3 required to produce this effect (Lachmann et al., 1973) . Results are expressed as site-forming units (SFU). One SFU is the amount of C3 required to lyse one EAI42 cell.
The inhibitory effect of Ross River virus on C3 cleavage by activated factor B was quantified in a trypsinactivated amplification convertase inhibition assay, TACI (Bitter-Suermann et al., 1981) . Equal volumes (10 ~1) of the following pre-washed reagents were mixed in the order shown: pure guinea-pig C3 (450),tg/ml); trypsin (5/_Lg:ml), VBSS, virus and,,or factor H; /'actor B (35/_~g/ml). After incubating mixtures at 37 °C, 5 ~1 soybean trypsin inhibitor (15 gg/ml, Sigma) was added and the mixtures transferred to ice (4 °C) to stop the reaction. Levels of uncleaved C3 were then assayed in the haemolytic assay described above.
In order to study the effect of virus on the alternative pathway in more detail, C3bBb complexes (X) were assembled on zymosan (Z) particles (Sigma). The procedure has been described elsewhere (Brade et aL, 1974a) as have the methods of preparing decayed ZX (ZX d2) and regenerating ZX from ZX d2 with factor B and factor D (Brade et al., 1974a) . Briefly zymosan was boiled for 30 min in isotonic saline and then resuspended in fresh saline at a concentration of 4 mg/ml. Before use, the zymosan was washed twice in VBSS and fresh warm (27 °C) guineapig or human serum diluted | in 10 in VBSS added to a zymosan pellet to give a zymosan concentration of 1 mg per ml. After 5 min incubation at 27 °C the zymosan pellet with C3bBb complexed to it (ZX) was washed twice in VBSS and used immediately or incubated at 37 °C for 2 h to prepare decayed ZX d2, which was washed twice in VBSS and stored at a concentration of 4 mg/ml at -20 °C until use.
Regenerated ZX was prepared by washing thawed ZX d2 twice in VBSS and adding 100 ~.tl factor B and 100 ~tl factor D to a 0.4 mg pellet ofZX az. The pellet was resuspended in this mixture and incubated at 27 °C for 15 min. The ZX was then washed twice in ice-cold VBSS before use. Variations to this basic procedure are detailed in the text.
RESULTS

Effect of Ross River virus on classical and alternative pathway-mediated haemolysis
Incubation of 10 ~tl Ross River virus with 90 t-tl aliquots of normal or C4-deficient guineapig sera for 1 h at 37 °C resulted in an apparent increase in levels of C3 relative to a control of Fig. 1 . The magnitude of the increase was related to the amount of virus added. Addition of a similar amount of virus to serum heated to 56 °C for, 30 rain did not result in an apparent increase in levels of C3.
When the rate of loss of C3 activity in normal and C4-deficient guinea-pig serum was examined in three separate experiments it was noted that addition of 107 TCIDs0 of virus to 100 gl serum slowed the spontaneous rate of decay of C3 activity and that there was no absolute increase in C3 activity in virus-serum mixtures. Fig. 2 shows representative data obtained from one of these experiments.
Effect of Ross River virus on the cleavage of C3 by factor B and C2
Since virus appeared to inhibit the spontaneous decay of C3 which occurred in unheated serum, the interaction of virus with the C3-cleaving complement enzymes C4bC2a with C2 as the enzymic centre and C3bBb with Bb as the enzymic centre was investigated. Incubation of 10 ~tl pure guinea-pig C3 with 10 lal VFBb and 10 ~tl VBSS for 5 min at 37 °C resulted in cleavage of more than 95 ~o of the C3 (Fig. 3) . Addition of 10 ~tl virus diluted in VBSS to this mixture, in place of VBSS, inhibited the action of VFBb. The magnitude of the inhibition was related to the amount of virus in the 10 gl aliquot added. Immunoelectrophoresis of mixtures of VFBb and virus which had been incubated for up to 15 min at 37 °C failed to show any breakdown of the VFBb complex (data not shown). The presence of any free VF or Bb from this complex was detected by their electrophoretic mobility and reaction with goat anti-VF or goat anti-B.
These experiments suggested that virus interfered with the cleavage of C3 by the C3bBb complex but they did not indicate whether virus acted on C3, Bb, or both. The ability of factor B to combine with C3b on ZX ~2 particles and to be cleaved by factor D was therefore studied. ZX (0.4 mg/tube) generated by incubation of zymosan in normal human or guinea-pig serum (Brade et al., 1974a) was resuspended in 50/_tl of VBSS, or a solution of virus in VBSS, and 400 ~tl C3 added to the slurry. These mixtures were then incubated at 37 °C for 15 min before the ZX was pelleted at 9800 g for 30 s. The supernatant was removed, diluted in VBSS and residual C3 levels were determined. ZX generated in this manner cleaved guinea-pig C3 but addition of virus inhibited the breakdown of haemolytically active C3. However if ZX was washed twice by centrifugation at 9800 g for 30 s in VBSS after incubation with virus and before addition of C3, the inhibitory effect of the virus was abolished (Table 1 , expt. l, lines 5 and 6).
To determine whether factor B could be cleaved in the presence of virus the following experiments were performed. ZX d2 (0"4 mg/tube) was incubated with 100 lal factor B and 100 gl factor D for 15 min at 27 °C and then washed twice in ice-cold VBSS before 100 gl VBSS, or virus diluted in VBSS, was used to resuspend the ZX pellet. After incubating these ZX suspensions for 30 min at 4 °C, 400/.tl guinea-pig C3 was added to each tube and the mixtures incubated at 37 °C for 15 min before the ZX was removed and residual C3 assayed. As can be seen (Table 2, expt. 1) this procedure reconstituted the lytic activity of ZX a2 but the addition of virus after formation of ZX inhibited the cleavage of C3. However, if ZX virus mixtures were washed in ice-cold VBSS before adding C3 the inhibitory effect of virus on cleavage of C3 by ZX was abolished (Table 2, expt. 2). In a third experiment 0-4 mg ZX d2 was incubated with 100 ~tl virus or VBSS at 4 °C for 30 min before addition of 100 ~tl of factor B and 100 B1 factor D and then raising the incubation temperature to 27 °C for 15 min. Following this incubation step, the ZX was washed twice in ice-cold VBSS and 40 ~tl C3 added for 15 min incubation at 37 °C. ZX was then removed and residual C3 assayed. ZX reconstituted in this manner cleaved C3 but virus no longer had any effect on cleavage of C3 by the reconstituted ZX (Table 2, expt. 3). In a TACI assay, addition of 10 B1 trypsin to mixtures of 10 ~tl guinea-pig C3, 10 ~tl factor B and 10 ~tl VBSS resulted in rapid breakdown of C3 (Fig. 4a, open circles) . Addition of 10 ~tl virus to this mixture (closed circles) in place of VBSS inhibited cleavage of C3, However virus (closed squares) did not alter the rate of C3 cleavage by trypsin in the absence of factor B (open squares). Addition of 10 ~tl factor H to the trypsin, factor B and C3 in the reaction mixture also inhibited C3 cleavage (Fig. 4b) . When 10 pl virus was added to the trypsin, factor B, factor H and C3 reaction, the inhibition of C3 breakdown was greater than when either factor H or virus was added alone. The interaction between Ross River virus and C2 was investigated by measuring the amount of homologous C3 bound to EAC142 cells in the presence or absence of virus. Fifty pl of either Ross River virus or VBSS was added to 1.3 x 10 s EAC142 cells and incubated at 4 °C for 15 min before addition of 100 pl of a range of dilutions of C3. These mixtures were incubated at 37 °C for 30 min, the EAC142 cells washed twice in cold VBSS, and the amount of C3 bound was estimated in an haemolysis assay using guinea-pig components. As can be seen in Table 3 , lysis of EAC142 cells was lower in mixtures containing virus and C3 than in those containing C3 and VBSS. Deposition of C3b on erythrocytes sensitized with homologous C2 (EAC142) was inhibited by virus in both guinea-pig and human systems.
DISCUSSION
Unlike the Alphavirus type strain Sindbis, Ross River virus did not appear to activate either the classical or alternative complement pathway in the absence of antibody. Instead, Ross River virus was found to inhibit the cleavage of C3 by both factor B and C2. It is also possible that in whole serum Ross River virus inhibited cleavage of C3 by serum proteases unrelated to the complement system.
Activation of the alternative pathway by Sindbis virus appears to be inversely related to the sialic acid content of the virus envelope (Hirsch et al., 1981) . If this was a causal relationship then it would tend to support the concept (Fearon, 1978) that surface-bound sialic acid enhances factor H binding to C3b, resulting in inhibition of activation. Although we have no data on the sialic acid content of the Ross River virus preparations used in this study it is unlikely that the failure of the virus to activate either complement pathway was due to a virus-factor H interaction because the inhibition by Ross River virus of C3 cleavage could be demonstrated in the absence of factor H.
Although the effect of Ross River virus and factor H on cleavage of C3 appeared to be additive, their sites of action are probably different. Factor H is known to bind to C3b (Weiler et al., 1976) but the following evidence suggests that Ross River virus acts at the level of Bb. (i) Ross River virus inhibited the cleavage of C3 by VFBb without disrupting the VFBb complex.
(ii) In the TACI assay the rate of C3 breakdown by trypsin was the same in mixtures with and without virus, indicating that virus did not block generation of C3b from C3 by trypsin. Evidence that C3b was generated came from the rapid decay of C3 when pure factor B was added to the trypsin-C3 mixture in the absence of virus. It is possible though that virus acted by preventing cleavage of factor B by trypsin. (iii) Virus did not prevent cleavage of factor B by factor D in the regenerated ZX system. These experiments ( Table 2 ) also showed that B bound to ZX dz in the presence of virus. However, removal of the inhibitory effect of virus by washing ZX t~r ZX d2 particles before addition of C3 indicated that if a Bb-virus bond existed it was a weak one.
It was not possible to explore the nature of the inhibition of generation of an active EAC 142-C3 complex in the detail used for the C3bBb complex of the alternative pathway. As a result it has not been possible to show whether C3 bound to EAC142 but was not cleaved in the presence of virus, or whether it did not bind at all.
It seems likely then that Ross River virus acts on the alternative complement pathway by binding weakly to Bb and acting as a substrate in competition with C3. A similar inhibition could also occur in the classical pathway if Ross River virus acted as a substrate for EAC142. If this is the manner in which this virus inhibits the complement pathway, further experiments should test whether the action of these two proteolytic complement enzymes (C2 and B) alters the infectivity of Ross River virus.
A feature of this study and those with Sindbis virus (Hirsch et al., 1980a (Hirsch et al., , b, 1981 was the large amount of virus required in vitro to produce the effects described (107 to 108 TCID50 Ross River virus, 106 to l08 p.f.u. Sindbis). We are unaware of any reports of this amount of virus being isolated from man or a mosquito vector. However, it is possible that in the vicinity of a focus of infected cells in vivo these levels of virus are reached.
The contrasting effects of Sindbis and Ross River viruses on the complement system are not incompatible with some of the reported patterns of human disease. Ross River virus (complement pathway inhibitor) causes only a faint maculopapular rash in approximately onethird of all cases of clinical infection (Aaskov et al., 1981 a, Mudge, 1977 whereas Sindbis virus (complement activator) is reported to produce large vesicular lesions some of which may have haemorrhagic manifestations (Taylor et al., 1955; Guard et al., 1982) .
Since Ross River virus does not activate either complement pathway in the absence of antibody it is unlikely that complement plays any role in vivo in the clearance of virus from nonimmune hosts. The ability of this virus to inhibit cleavage of C3 may also impede the destruction of virus and virus-infected tissue in an immune host. These factors may have contributed to Ross River virus having become such a successful human pathogen.
